Alnylam Replaces Sanofi Partnership With Second Regeneron Tie-Up For RNAi Drugs

Already partnered with Regeneron in NASH, Alnylam unveils a new R&D collaboration in eye, CNS and liver indications, after Alnylam and Sanofi end the research phase of their relationship.